## Chapters
0:00 The Gilead Story
3:58 Earnings Overview
Gilead Sciences just reported Q1 2026 earnings — margins hit 88%.
Here's what the double beat means for GILD and whether the bull case is playing out.
🔔 Subscribe for weekly deep dives on every Russell 1000 earnings report: https://www.youtube.com/@ChargedAlpha?sub_confirmation=1
📊 Key Financial Highlights:
• Revenue: $7.0B vs $6.9B expected (+1.5% beat)
• Gross Margin: 87.5%
• Free Cash Flow: $9.8B TTM
• Forward P/E: 15.1x
• Analyst Consensus: Buy, $158 avg price target (0% upside)
📈 Free stock screening tools — no signup, no paywall:
https://chargedalpha.com
🎧 Also available as a podcast:
https://chargedalpha.podbean.com
#stocks #GILD #earnings #stocks #investing #stockmarket #earningsseason #wallstreet #GileadSciences
---
Financial data and charts: Financial Modeling Prep (https://financialmodelingprep.com)
⚖️ Disclaimer: This video is for informational and educational purposes only. Nothing discussed constitutes a buy, sell, or hold recommendation. All investments carry risk. Past performance does not guarantee future results. Always do your own research and consult a qualified financial advisor. Hosts may hold positions in securities discussed. This episode was researched, written, and produced using AI-assisted tools. Data sourced from public filings and may contain inaccuracies.
Watch on YouTube: https://www.youtube.com/watch?v=NrFbjZHz0wk